|
Results from This Site: 31 - 40 of 68 total results for GlaxoSmithKline
-
acquisition of the Lucozade and Ribena brands from GlaxoSmithKline for £1.35bn. The resulting business adopted the new name Lucozade Ribena Suntory. Lucozade had been owned by GlaxoSmithKline and its
-
Arixtra and Fraxiparine, were sold in 2004 to GlaxoSmithKline to appease merger regulators. Because of the split in revenues for Plavix, Sanofi's own top-selling drug has for several years been the slow-
-
drink Horlicks and other nutritional brands owned by GlaxoSmithKline. Advertising Who handles Hindustan Unilever's advertising? Click here for agency account assignments. The group declared advertising
-
through a worldwide marketing partnership with GlaxoSmithKline. However, Levitra's sales proved disappointing and GSK sold back to Bayer marketing rights in all markets except the US in 2005. The group'
-
not least sizeable asset-swapping deals in 2014 with GlaxoSmithKline and Eli Lilly. Advertising Who handles Novartis's advertising? Click here for Agency Account Assignments for Novartis from Adbrands.
-
GlaxoSmithKline $10.5bn Sanofi $4.8bn Amway $8.6bn Herbalife $4.4bn Procter & Gamble $7.5bn Pfizer $3.5bn Bayer $7.0bn Nature's Bounty $3.3bn Source: Igea, company reports; includes
-
jointly marketed with GlaxoSmithKline. The merger with Merck was the natural extension of an existing joint venture. Schering-Plough originally negotiated a long-term global partnership with Merck in
-
including GlaxoSmithkline. Other OTC products included Rogain/Regaine, Nasalcrom, PediaCare, Dramamine, Colpermin and Luden's. Acquired by Pfizer, they were later sold off to Johnson & Johnson with the
-
Gamble and GlaxoSmithKline, cut spend. Grey demonstrates its greatest strength when working in tandem with its counterpart agencies across Europe to roll out multi-market campaigns. Grey EMEA's skill
-
2,043m $1,930m $1,630m $1,560m 43 GlaxoSmithKline 22 2,000m $1,835m $1,672m $1,715m $1,620m 44 Netflix 1,450m $1,879m $1,808m $1,091m $842m $714m 45 Beiersdorf 23 1,772m $1,
|
All rights reserved © Mind Advertising Ltd 1998-2019
|